(Q44066559)

English

Randomized open trial for comparison of proton pump inhibitors in triple therapy for Helicobacter pylori infection in relation to CYP2C19 genotype

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Randomized open trial for comparison of proton pump inhibitors in triple therapy for Helicobacter pylori infection in relation to CYP2C19 genotype (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Helicobacter pylori

0 references

Helicobacter pylori infectious disease

1 reference

based on heuristic

inferred from title

author name string

Tomoki Inaba

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Motowo Mizuno

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Kozou Kawai

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Kenji Yokota

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Keiji Oguma

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Masatsugu Miyoshi

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Susumu Take

7

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Hiroyuki Okada

8

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Takao Tsuji

9

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

publication date

1 July 2002

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Journal of Gastroenterology and Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

748-753

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02790.X

21 January 2018

Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02790.X

21 January 2018

Kinetic studies of Helicobacter pylori urease inhibition by a novel proton pump inhibitor, rabeprazole.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02790.X

21 January 2018

The role of antisecretory drugs in the treatment of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02790.X

21 January 2018

Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02790.X

21 January 2018

Review article: cytochrome P450 and the metabolism of proton pump inhibitors--emphasis on rabeprazole

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02790.X

21 January 2018

Role of screening agar plates for in vitro susceptibility testing of Helicobacter pylori in a routine laboratory setting

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02790.X

21 January 2018

Review article: the pharmacology of rabeprazole

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02790.X

21 January 2018

Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection-comparison with omeprazole and lansoprazole.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02790.X

21 January 2018

Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection and CYP2C19 genetic polymorphism

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02790.X

21 January 2018

Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotypes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02790.X

21 January 2018

Comparison of the kinetic disposition of and serum gastrin change by lansoprazole versus rabeprazole during an 8-day dosing scheme in relation to CYP2C19 polymorphism

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02790.X

21 January 2018

CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02790.X

21 January 2018

Effects of genotypic differences in CYP2C19 status on cure rates for Helicobacter pylori infection by dual therapy with rabeprazole plus amoxicillin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02790.X

21 January 2018

A randomized open trial for comparison of proton pump inhibitors, omeprazole versus rabeprazole, in dual therapy for Helicobacter pylori infection in relation to CYP2C19 genetic polymorphism

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02790.X

21 January 2018

A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02790.X

21 January 2018

Identifiers

10.1046/J.1440-1746.2002.02790.X

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44066559&oldid=2106202518"